MAX negotiated prices for GeneXpert IV System and Xpert® BCR ABL assay and eligible country list
At the request of The MAX Foundation (MAX) and the International CML Foundation (iCMLf), Cepheid has agreed to offer a preferential price for the GeneXpert IV System and Xpert BCR-ABL Monitor Assay for public sector end users in 68 countries. This preferential pricing has been established through a collaboration agreement between MAX and Cepheid, and will only apply to orders placed by MAX to Cepheid. End users interested in taking advantage of the preferential pricing may inquire with MAX for guidance on how to access the program.
This document outlines the pricing, establishes the relationships, and defines the applicable market as the public sector in the 68 specified low-and-middle-income countries: Download PDF version
Please write to us at email@example.com if you wish to have a price quote put together for your clinic.
Posted by Pat Garcia-Gonzalez on June, 14, 2012
Touched by Max in the Philippines, modeling growth for other patient groups
Touched by Max, a patient group in the Philippines has just been registered as a Social Welfare & Development Agency in the country! This is a certification in the Philippines that will accord a number of extra benefits to Touched by Max and allow them to help patients in even more ways. Though certifications and accreditations are different in every country, other patient groups may want to explore similar options in order to provide the best possible support to patients and families. Today we have a guest blog from Mila, who shares Touched by Max’s successes!
Posted by Guest Blogger on June, 11, 2012
Follow us on Facebook!
Latest Blog Posts
Reminder: It is not too late to sign up for the upcoming July 5th Webinar hosted by Cepheid on the GeneXpert
The MAX 2011 Annual Report is here!